NCT00387179

Brief Summary

Jet lag and some sleep disorders are caused by a disruption in an individual's "internal clock." Understanding the most effective way to quickly re-adjust the body's internal clock will be beneficial for treating individuals with these conditions. This study will evaluate the combined effectiveness of light and non-light therapies at regulating sleep cycles and improving sleep quality.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2006

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 12, 2006

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

August 25, 2009

Status Verified

August 1, 2009

Enrollment Period

3.4 years

First QC Date

October 11, 2006

Last Update Submit

August 24, 2009

Conditions

Keywords

Circadian Rhythm Sleep Disorders

Outcome Measures

Primary Outcomes (1)

  • Circadian phase, as measured by the shift of the endogenous melatonin rhythm (measured during each inpatient visit)

    24 hour

Secondary Outcomes (3)

  • Circadian phase, as measured by the shift of the endogenous temperature rhythm

    24 hour

  • Sleep quality, as measured by wakefulness after sleep onset (electroencephalogram [EEG] defined wakefulness after 10 minutes of consecutive sleep) and number of awakenings

    overnight

  • Cognitive function, as measured by daytime sleepiness, reaction time, and mood and well being (all measured during each inpatient visit)

    24 h and daytime

Study Arms (3)

Dim Light Melatonin and/or methylxanthine

EXPERIMENTAL

Dim Light Melatonin and/or methylxanthine

Drug: MelatoninDrug: Methylxanthine

Placebo and Dim Light or bright light

EXPERIMENTAL

Placebo and Dim Light or bright light

Procedure: Light Therapy

Bright light melatonin and/or methylxanthine

EXPERIMENTAL

Bright light, melatonin, and/or methylxanthine

Drug: MelatoninDrug: MethylxanthineProcedure: Light Therapy

Interventions

5mg, pill, once

Also known as: Life Extension Melatonin 5 mg
Bright light melatonin and/or methylxanthineDim Light Melatonin and/or methylxanthine

2.9 mg/kg, pill, once

Bright light melatonin and/or methylxanthineDim Light Melatonin and/or methylxanthine
Light TherapyPROCEDURE

Bright light exposure

Bright light melatonin and/or methylxanthinePlacebo and Dim Light or bright light

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • In good general health, as determined by blood chemistries, urine toxicology, physical examination, and medical and psychiatric history

You may not qualify if:

  • History of any current or chronic disease, including any of the following:
  • Chronobiologic disorders
  • Sleep disorders
  • Cardiovascular disorders
  • Respiratory disorders
  • Kidney and urinary tract disorders
  • Infectious diseases
  • Gastrointestinal disorders
  • Immune system disorders
  • Connective tissue and joint disorders
  • Hematopoietic disorders
  • Neoplastic diseases
  • Endocrine and metabolic diseases
  • Neurologic disorders
  • Current or past history of drug abuse
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep and Chronobiology Laboratory

Boulder, Colorado, 80309, United States

RECRUITING

Related Publications (8)

  • Duffy JF, Wright KP Jr. Entrainment of the human circadian system by light. J Biol Rhythms. 2005 Aug;20(4):326-38. doi: 10.1177/0748730405277983.

    PMID: 16077152BACKGROUND
  • Wright KP Jr, Gronfier C, Duffy JF, Czeisler CA. Intrinsic period and light intensity determine the phase relationship between melatonin and sleep in humans. J Biol Rhythms. 2005 Apr;20(2):168-77. doi: 10.1177/0748730404274265.

    PMID: 15834113BACKGROUND
  • Gronfier C, Wright KP Jr, Kronauer RE, Jewett ME, Czeisler CA. Efficacy of a single sequence of intermittent bright light pulses for delaying circadian phase in humans. Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E174-81. doi: 10.1152/ajpendo.00385.2003. Epub 2004 Mar 23.

    PMID: 15039146BACKGROUND
  • Barger LK, Wright KP Jr, Hughes RJ, Czeisler CA. Daily exercise facilitates phase delays of circadian melatonin rhythm in very dim light. Am J Physiol Regul Integr Comp Physiol. 2004 Jun;286(6):R1077-84. doi: 10.1152/ajpregu.00397.2003. Epub 2004 Mar 18.

    PMID: 15031136BACKGROUND
  • Wright KP Jr, Czeisler CA. Absence of circadian phase resetting in response to bright light behind the knees. Science. 2002 Jul 26;297(5581):571. doi: 10.1126/science.1071697. No abstract available.

    PMID: 12142528BACKGROUND
  • Wright KP Jr, Hughes RJ, Kronauer RE, Dijk DJ, Czeisler CA. Intrinsic near-24-h pacemaker period determines limits of circadian entrainment to a weak synchronizer in humans. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14027-32. doi: 10.1073/pnas.201530198.

    PMID: 11717461BACKGROUND
  • Wright KP Jr, Myers BL, Plenzler SC, Drake CL, Badia P. Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives. Brain Res. 2000 Aug 11;873(2):310-7. doi: 10.1016/s0006-8993(00)02557-9.

    PMID: 10930561BACKGROUND
  • Wright KP Jr, Badia P, Myers BL, Plenzler SC, Hakel M. Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res. 1997 Jan 30;747(1):78-84. doi: 10.1016/s0006-8993(96)01268-1.

    PMID: 9042530BACKGROUND

Related Links

MeSH Terms

Conditions

Sleep Disorders, Circadian Rhythm

Interventions

MelatoninmethylxanthinePhototherapy

Condition Hierarchy (Ancestors)

Chronobiology DisordersNervous System DiseasesDyssomniasSleep Wake DisordersOccupational DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone AntagonistsTherapeutics

Study Officials

  • Kenneth P. Wright, PhD

    University of Colorado at Boulder

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
NIH

Study Record Dates

First Submitted

October 11, 2006

First Posted

October 12, 2006

Study Start

October 1, 2006

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

August 25, 2009

Record last verified: 2009-08

Locations